HR. 9682In Committee
Cure Hepatitis C Act of 2026
Plain-English overview
What this bill does
Establishes a federally funded hepatitis C treatment and screening program that makes drugs free for specified high-risk populations and temporarily waives Medicare cost sharing
Key points
- Establish hepatitis C drug purchasing program
- Authorize grants for screening and treatment
- Allow Medicare drugs without cost sharing
Current status
Where it stands
Status
In Committee
Latest action
2026-07-14 — Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
Select a topic to continue exploring related legislation, members, and committees.
Discovery signals
About these signals
Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.
Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.